[1] Pittenger MF, Mackay AM, Beck SC, et al.  Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411): 143-147.   doi: 10.1126/science.284.5411.143
[2]

Lin WP, Huang LF, Li Y, et al. Mesenchymal stem cells and cancer: clinical challenges and opportunities[J/OL]. Biomed Res Int, 2019, 2019: 2820853[2019-09-16]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530243. DOI: 10.1155/2019/2820853.
[3] Cheng S, Nethi SK, Rathi S, et al.  Engineered mesenchymal stem cells for targeting solid tumors: therapeutic potential beyond regenerative therapy[J]. J Pharmacol Exp Ther, 2019, 370(2): 231-241.   doi: 10.1124/jpet.119.259796
[4] Wu J, Liu Y, Tang YX, et al.  Synergistic chemo-photothermal therapy of breast cancer by mesenchymal stem cell-encapsulated yolk-shell GNR@HPMO-PTX nanospheres[J]. ACS Appl Mater Interfaces, 2016, 8(28): 17927-17935.   doi: 10.1021/acsami.6b05677
[5] Suryaprakash S, Lao YH, Cho HY, et al.  Engineered mesenchymal stem cell/nanomedicine spheroid as an active drug delivery platform for combinational glioblastoma therapy[J]. Nano Lett, 2019, 19(3): 1701-1705.   doi: 10.1021/acs.nanolett.8b04697
[6] Crisan M, Yap S, Casteilla L, et al.  A perivascular origin for mesenchymal stem cells in multiple human organs[J]. Cell Stem Cell, 2008, 3(3): 301-313.   doi: 10.1016/j.stem.2008.07.003
[7] Yoo JW, Irvine DJ, Discher DE, et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers[J]. Nat Rev Drug Discov, 2011, 10(7): 521-535.   doi: 10.1038/nrd3499
[8] Wolfs E, Struys T, Notelaers T, et al.  18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity[J]. J Nucl Med, 2013, 54(3): 447-454.   doi: 10.2967/jnumed.112.108316
[9] Zischek C, Niess H, Ischenko I, et al.  Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma[J]. Ann Surg, 2009, 250(5): 747-753.   doi: 10.1097/SLA.0b013e3181bd62d0
[10] Cao BR, Yang MY, Zhu Y, et al.  Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy[J]. Adv Mater, 2014, 26(27): 4627-4631.   doi: 10.1002/adma.201401550
[11]

Noorwali A, Faidah M, Ahmed N, et al. Tracking iron oxide labelled mesenchymal stem cells (MSCs) using magnetic resonance imaging (MRI) in a rat model of hepatic cirrhosis[J/OL]. Bioinformation, 2019, 15(1): 1−10[2019-09-16]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651036. DOI: 10.6026/97320630015001.
[12] Tang YH, Zhang CF, Wang JX.  MRI/SPECT/fluorescent tri-modal probe for evaluating the homing and therapeutic efficacy of transplanted mesenchymal stem cells in a rat ischemic stroke model[J]. Adv Funct Mater, 2015, 25(7): 1024-1034.   doi: 10.1002/adfm.201402930
[13]

Pei ZJ, Zeng J, Song YF, et al. In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction[J/OL]. Sci Rep, 2017, 7(1): 6296[2019-09-16]. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28740146. DOI: 10.1038/s41598-017-06571-8.